Cannabis use, unspecified with psychotic disorder with delusions
ICD-10 F12.950 is a billable code used to indicate a diagnosis of cannabis use, unspecified with psychotic disorder with delusions.
F12.950 refers to a condition characterized by the use of cannabis leading to a psychotic disorder, specifically with delusions. This diagnosis is often seen in individuals who consume cannabis in varying amounts and frequencies, leading to significant alterations in perception, thought processes, and behavior. The psychotic symptoms can manifest as delusions, which are false beliefs that are firmly held despite contradictory evidence. These delusions can significantly impair social and occupational functioning. The onset of symptoms may occur during or shortly after cannabis use, and the severity can vary based on individual susceptibility, the potency of the cannabis used, and the presence of other mental health disorders. Treatment typically involves a combination of psychiatric intervention, including antipsychotic medications, and substance use disorder therapies, such as cognitive-behavioral therapy (CBT) and motivational interviewing. Understanding the interplay between cannabis use and psychotic disorders is crucial for effective management and recovery.
Detailed mental status examination, history of substance use, and assessment of delusions.
Patients presenting with acute psychosis after cannabis use, chronic cannabis users developing psychotic symptoms.
Consideration of differential diagnoses and the need for a comprehensive treatment plan.
Substance use history, treatment history, and psychosocial assessment.
Patients in withdrawal from cannabis with psychotic symptoms, those in recovery experiencing relapse.
Integration of substance use treatment with mental health care.
Used for follow-up visits for patients diagnosed with cannabis use disorder and psychotic symptoms.
Document history of present illness, review of systems, and mental status examination.
Psychiatrists should ensure thorough documentation of mental health assessments.
F12.950 includes the presence of delusions as part of the psychotic disorder, while F12.930 does not specify the presence of delusions, indicating a broader category of cannabis-related psychosis.